GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Market Cap

Haleon (Haleon) Market Cap : $37,785 Mil (As of May. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Haleon's share price for the quarter that ended in Mar. 2024 was $8.49. Haleon's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 4,566 Mil. Therefore, Haleon's market cap for the quarter that ended in Mar. 2024 was $38,767 Mil.

Haleon's quarterly market cap declined from Sep. 2023 ($38,462 Mil) to Dec. 2023 ($38,000 Mil) but then increased from Dec. 2023 ($38,000 Mil) to Mar. 2024 ($38,767 Mil).

Haleon's annual market cap increased from Dec. 2021 ($0 Mil) to Dec. 2022 ($36,938 Mil) and increased from Dec. 2022 ($36,938 Mil) to Dec. 2023 ($38,000 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Haleon's Enterprise Value for Today is $48,459 Mil.


Haleon Market Cap Historical Data

The historical data trend for Haleon's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Market Cap Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - - 36,938.32 38,000.30

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37,584.74 38,692.89 38,462.03 38,000.30 38,766.61

Competitive Comparison of Haleon's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haleon's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Market Cap distribution charts can be found below:

* The bar in red indicates where Haleon's Market Cap falls into.



Haleon Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Haleon's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$8.23*4617.29
=$38,000

Haleon's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=$8.49*4566.15
=$38,767

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haleon  (NYSE:HLN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Haleon Market Cap Related Terms

Thank you for viewing the detailed overview of Haleon's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (Haleon) Business Description

Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.